[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"may-thurner-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:may-thurner-syndrome":37},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,53],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100487581","vascular-lab-resource-vlr-biorepository-100487581",false,"NCT05628948","Vascular Lab Resource (VLR) Biorepository","Vascular Lab Resource (VLR) Biorepository Study","Inclusion Criteria:\n\n1. 18 years or older\n2. Subjects capable of providing informed consent document\n3. Subjects with diagnosed with or at risk for cardiovascular and metabolic diseases\n\nExclusion Criteria:\n\n1. Known life expectancy of ≤ 6 months at the time of enrollment\n2. Known current pregnancy\n3. Severe Anemia (last documented hemoglobin \\\u003C 7.0 g\u002FdL)","ALL","18 Years",{"count":19,"type":20},500,"ESTIMATED","OBSERVATIONAL","This is a study of biomarkers obtained from prospectively collected subject samples and their correlation with cardiovascular and metabolic diseases. The purpose of this initiative is to develop an enduring tool to allow for collaborative research between clinicians at Cleveland Clinic Main Campus and basic scientists at the Lerner Research Institute. This collaboration will allow resources to be available to clinical and basic researchers alike. This tool will enable research of vascular disease in the Vascular Lab and will leverage this valuable asset to the fullest extent to allow for interdepartmental collaboration.",[24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39],"Cardiovascular Diseases","Metabolic Disease","Peripheral Artery Disease","Carotid Disease","Aneurysmal Disease","Venous Disease","Thrombosis","Lymphedema","Lipedema","Non-Atherosclerotic Chronic Arterial Occlusive Disease","Vasculitis","Fibromuscular Dysplasia","Arterial Dissection","May-Thurner Syndrome","Thoracic Outlet Syndrome","Vasospasm","RECRUITING","2025-12-15",{"date":43,"type":44},"2025-12-19","ACTUAL",{"date":46,"type":44},"2019-11-14",{"date":48,"type":20},"2031-06-30",{"name":50,"class":51},"The Cleveland Clinic","OTHER",1,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":4,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":16,"minAge":17,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":52},"100584337","pelvic-vein-quantitative-flow-characterization-using-2d-and-4d-flow-mri-100584337","NCT06888024","Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI","Arm 1: Inclusion Criteria:\n\n• No self-reported history of pelvic or iliac venous disease or associated symptoms\n\nExclusion Criteria:\n\n* History of pelvic or iliac venous disease or intervention\n* Contraindication to MRI examination\n* Prisoners\n* Subjects ≤ 18 years of age\n* Pregnant women\n* Adults unable to provide informed consent\n\nArm 2: Inclusion Criteria:\n\n• Clinical symptoms or imaging findings compatible with left iliac vein compression syndrome\n\nExclusion Criteria:\n\n* History of pelvic or iliac venous intervention\n* Contraindication to MRI examination\n* Prisoners\n* Subjects ≤ 18 years of age\n* Pregnant women\n* Adults unable to provide informed consent\n\nArm 3: Inclusion Criteria:\n\n• History of left iliac vein stent placement\n\nExclusion Criteria:\n\n* Contraindication to MRI examination\n* Prisoners\n* Subjects ≤ 18 years of age\n* Pregnant women\n* Adults unable to provide informed consent",true,"89 Years",{"count":62,"type":20},15,"INTERVENTIONAL",[65],"NA","The purpose of the study is to quantitatively characterize the flow in the pelvic venous structures using 2D and 4D flow MRI with the objective of establishing physiologic and pathologic parameters for downstream computational fluid dynamics analysis.\n\nArm 1: To establish the baseline flow characteristics of the iliac veins in patients with no imaging evidence of iliac venous disease.\n\nArm 2: To assess the flow characteristics of the iliac veins in patients with left iliac vein compression syndrome (a.k.a. May-Thurner syndrome).\n\nArm 3: To assess the flow characteristics of the iliac veins in patients status post iliac stent placement.",[37,68],"Iliac Venous Compression",[37,70],"Iliac Venous Disease","2025-09-18",{"date":73,"type":44},"2025-09-24",{"date":75,"type":44},"2025-04-01",{"date":77,"type":20},"2027-01-01",{"name":79,"class":51},"Ningcheng Peter Li"]